NCT00951600View on ClinicalTrials.gov

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

oxcarbazepine 300 mg/5mL oral suspension

Trial Locations (1)

Unknown

Ranbaxy Clinical Pharmacology Unit, Ranbaxy Laboratories Limited, Noida

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00951600 - Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions | Biotech Hunter | Biotech Hunter